AGIO Trading Below Director's Recent Buy Price

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 16, Agios Pharmaceuticals Inc's Director, David Scadden, invested $16,688.00 into 200 shares of AGIO, for a cost per share of $83.44..